Showing results (111-120 of 203) with videos related to

Sort By:
Pageof 21
American Heart Journal|March 1, 2014
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillationMenno V Huisman, Gregory Y H Lip, Hans C Diener, et al.
Journal of the American College of Cardiology|February 18, 2017
The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2Menno V Huisman, Kenneth J Rothman, Miney Paquette, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 16, 2022
Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registryMenno V Huisman, Christine Teutsch, Shihai Lu, et al.
Global Heart|March 25, 2017
The World Heart Federation Roadmap for Nonvalvular Atrial FibrillationAdrianna Murphy, Amitava Banerjee, Günter Breithardt, et al.
Thrombosis and Haemostasis|December 7, 2017
Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II RegistryMichał Mazurek, Menno V Huisman, Kenneth J Rothman, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 28, 2021
Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48Marc P Bonaca, Elliott M Antman, Jonathan W Cunningham, et al.
American Heart Journal|April 15, 2018
Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registryMenno V Huisman, Kenneth J Rothman, Miney Paquette, et al.
JAMA Cardiology|January 19, 2017
The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A ReviewPaul L Hess, Jeff S Healey, Christopher B Granger, et al.
Journal of the American College of Cardiology|September 23, 2017
Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial FibrillationMiney Paquette, Lionel Riou França, Christine Teutsch, et al.
European Heart Journal|August 30, 2011
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairmentKeith A A Fox, Jonathan P Piccini, Daniel Wojdyla, et al.
Pageof 21